389 related articles for article (PubMed ID: 23958917)
1. Origins of aberrant DNA methylation in acute myeloid leukemia.
Schoofs T; Berdel WE; Müller-Tidow C
Leukemia; 2014 Jan; 28(1):1-14. PubMed ID: 23958917
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation as a pathogenic event and as a therapeutic target in AML.
Schoofs T; Müller-Tidow C
Cancer Treat Rev; 2011; 37 Suppl 1():S13-8. PubMed ID: 21612874
[TBL] [Abstract][Full Text] [Related]
3. Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.
Boila LD; Sengupta A
Exp Hematol; 2020 Dec; 92():19-31. PubMed ID: 32950598
[TBL] [Abstract][Full Text] [Related]
4. Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications.
Yang X; Wong MPM; Ng RK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31527484
[TBL] [Abstract][Full Text] [Related]
5. Prognostic DNA methylation patterns in cytogenetically normal acute myeloid leukemia are predefined by stem cell chromatin marks.
Deneberg S; Guardiola P; Lennartsson A; Qu Y; Gaidzik V; Blanchet O; Karimi M; Bengtzén S; Nahi H; Uggla B; Tidefelt U; Höglund M; Paul C; Ekwall K; Döhner K; Lehmann S
Blood; 2011 Nov; 118(20):5573-82. PubMed ID: 21960591
[TBL] [Abstract][Full Text] [Related]
6. A Dysregulated DNA Methylation Landscape Linked to Gene Expression in MLL-Rearranged AML.
Koldobskiy MA; Abante J; Jenkinson G; Pujadas E; Tetens A; Zhao F; Tryggvadottir R; Idrizi A; Reinisch A; Majeti R; Goutsias J; Feinberg AP
Epigenetics; 2020 Aug; 15(8):841-858. PubMed ID: 32114880
[TBL] [Abstract][Full Text] [Related]
7. [Aberrant DNA methylation and its targeted therapy in acute myeloid leukemia].
Li X; Zhu L; Ye X
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2016 May; 45(4):387-394. PubMed ID: 27868412
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially methylated markers among cytogenetic risk groups of acute myeloid leukemia.
Qu X; Davison J; Du L; Storer B; Stirewalt DL; Heimfeld S; Estey E; Appelbaum FR; Fang M
Epigenetics; 2015; 10(6):526-35. PubMed ID: 25996682
[TBL] [Abstract][Full Text] [Related]
9. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of genome-wide DNA methylation studies in acute myeloid leukemia.
Li Y; Xu Q; Lv N; Wang L; Zhao H; Wang X; Guo J; Chen C; Li Y; Yu L
J Hematol Oncol; 2017 Feb; 10(1):41. PubMed ID: 28153026
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia.
Tao YF; Fang F; Hu SY; Lu J; Cao L; Zhao WL; Xiao PF; Li ZH; Wang NN; Xu LX; Du XJ; Sun LC; Li YH; Li YP; Xu YY; Ni J; Wang J; Feng X; Pan J
BMC Cancer; 2015 Oct; 15():756. PubMed ID: 26490736
[TBL] [Abstract][Full Text] [Related]
12. Early B-cell factor 3 (EBF3) is a novel tumor suppressor gene with promoter hypermethylation in pediatric acute myeloid leukemia.
Tao YF; Xu LX; Lu J; Hu SY; Fang F; Cao L; Xiao PF; Du XJ; Sun LC; Li ZH; Wang NN; Su GH; Li YH; Li G; Zhao H; Li YP; Xu YY; Zhou HT; Wu Y; Jin MF; Liu L; Zhu XM; Ni J; Wang J; Xing F; Zhao WL; Pan J
J Exp Clin Cancer Res; 2015 Jan; 34(1):4. PubMed ID: 25609158
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions.
Kim TK; Gore SD; Zeidan AM
Semin Hematol; 2015 Jul; 52(3):172-83. PubMed ID: 26111464
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Study of Aberrant CpG Island Hypermethylation of
Sun J; Zhang J; Wang Y; Li Y; Zhang R
Int J Med Sci; 2019; 16(2):324-330. PubMed ID: 30745814
[No Abstract] [Full Text] [Related]
15. Epigenetics in AML.
Melnick AM
Best Pract Res Clin Haematol; 2010 Dec; 23(4):463-8. PubMed ID: 21130408
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic targeting and personalized approaches for AML.
Roboz GJ
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):44-51. PubMed ID: 25696833
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia.
Alvarez S; Suela J; Valencia A; Fernández A; Wunderlich M; Agirre X; Prósper F; Martín-Subero JI; Maiques A; Acquadro F; Rodriguez Perales S; Calasanz MJ; Roman-Gómez J; Siebert R; Mulloy JC; Cervera J; Sanz MA; Esteller M; Cigudosa JC
PLoS One; 2010 Aug; 5(8):e12197. PubMed ID: 20808941
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylome analysis reveals methylation subtypes with different clinical outcomes for acute myeloid leukemia patients.
Gao H; He X; Li Q; Wang Y; Tian Y; Chen X; Wang J; Guo Y; Wang W; Li X
Cancer Med; 2020 Sep; 9(17):6296-6305. PubMed ID: 32628355
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.
Jiang Y; Dunbar A; Gondek LP; Mohan S; Rataul M; O'Keefe C; Sekeres M; Saunthararajah Y; Maciejewski JP
Blood; 2009 Feb; 113(6):1315-25. PubMed ID: 18832655
[TBL] [Abstract][Full Text] [Related]
20. Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation.
Yang F; Gong Q; Shi W; Zou Y; Shi J; Wei F; Li Q; Chen J; Li WD
Tumour Biol; 2016 Sep; 37(9):12609-12618. PubMed ID: 27405564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]